DOCS vs VEEV
DOCS: Doximity operates the leading professional network for U.S. physicians, providing a digital platform that streamlines clinical workflows and connects healthcare providers with commercial and career opportunities. VEEV: Veeva is the dominant cloud software and data platform powering the global life sciences industry from drug development through commercialization, with AI-enhanced solutions and a 16% annual revenue growth trajectory.
Side-by-side fundamentals
| Metric | DOCS | VEEV | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $20.99 | $194.46 | |
| Market cap as of 2026-08-01 | $3.8B | $31.6B | |
| P/E as of 2026-08-01 | 19.47 | 35.15 | DOCS lower |
| PEG as of 2026-08-01 | n/a | 1.89 | |
| Net margin as of 2026-08-01 | +30.4% | +28.4% | DOCS higher |
| Gross margin as of 2026-08-01 | +89.1% | +75.0% | DOCS higher |
| Operating margin as of 2026-08-01 | +33.3% | +28.8% | DOCS higher |
| ROE as of 2026-08-01 | +19.4% | +13.4% | DOCS higher |
| ROA as of 2026-08-01 | +16.5% | +11.0% | DOCS higher |
| Debt / equity as of 2026-08-01 | 0.00 | 0.00 | Tie |
| Revenue growth (YoY) as of 2026-08-01 | +13.1% | +16.3% | VEEV higher |
| Revenue CAGR (3y) SEC XBRL | +15.5% | +14.0% | DOCS higher |
| Beta as of 2026-08-01 | 1.21 | 0.91 | |
| 1-year return as of 2026-07-27 close | -65.5% | -33.0% | VEEV higher |
Fundamentals: market data, as of 2026-08-01. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.